Daniel Shames

Daniel Shames

Director/Board Member at MEREO BIOPHARMA GROUP PLC

Net worth: - $ as of 29/04/2024

Consumer Services
Health Technology
Government

Profile

Daniel Shames is the founder of Carolina Urocorp, Inc. He is currently a Non-Executive Director at Mereo BioPharma Group Plc.
Previously, he worked as the Deputy Director-Office of Drug Evaluation III at the US Food & Drug Administration from 2006 to 2008.
He also served as the President of Daniel A Shames Consulting, Inc. Dr. Shames completed his undergraduate degree at Brandeis University and obtained a doctorate from Georgetown University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/02/2024 0 ( -.--% ) - $ 29/04/2024

Daniel Shames active positions

CompaniesPositionStart
MEREO BIOPHARMA GROUP PLC Director/Board Member 09/11/2022
All active positions of Daniel Shames

Former positions of Daniel Shames

CompaniesPositionEnd
Corporate Officer/Principal 31/12/2007
Daniel A Shames Consulting, Inc. President -
Carolina Urocorp, Inc. Founder -
See the detail of Daniel Shames's experience

Training of Daniel Shames

Georgetown University School of Medicine Doctorate Degree
Brandeis University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Shames's experience

Connections

57

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
MEREO BIOPHARMA GROUP PLC

Health Technology

Private companies3
Carolina Urocorp, Inc.

Government

Daniel A Shames Consulting, Inc.

See company connections